PAPER Yamagishi S
SEARCH RESULTS
329930 RESULTS
PAPER Kroksveen AC, Opsahl JA, Aye TT, Ulvik RJ, Berven FS
Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
J Proteomics. 2011 Apr 1;74(4):371-88. PubMed: 21111852PAPER Ko CY, Chang LH, Lee YC, Sterneck E, Cheng CP, Chen SH, Huang AM, Tseng JT, Wang JM
CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells.
Neurobiol Aging. 2012 Feb;33(2):422.e11-25. PubMed: 21112127PAPER Nithianantharajah J, Hannan AJ
Mechanisms mediating brain and cognitive reserve: experience-dependent neuroprotection and functional compensation in animal models of neurodegenerative diseases.
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):331-9. PubMed: 21112312PAPER Kurata T, Miyazaki K, Kozuki M, Panin VL, Morimoto N, Ohta Y, Nagai M, Ikeda Y, Matsuura T, Abe K
Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.
Brain Res. 2011 Jan 31;1371:161-70. PubMed: 21112317PAPER Humpel C
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?
Exp Gerontol. 2011 Apr;46(4):225-32. PubMed: 21112383PAPER Barr TL, Alexander S, Conley Y
Gene expression profiling for discovery of novel targets in human traumatic brain injury.
Biol Res Nurs. 2011 Apr;13(2):140-53. PubMed: 21112922PAPER Jang YH, Min do
Nuclear localization of phospholipase D1 mediates the activation of nuclear protein kinase C(alpha) and extracellular signal-regulated kinase signaling pathways.
J Biol Chem. 2011 Feb 11;286(6):4680-9. PubMed: 21113078PAPER Kutzing MK, Langhammer CG, Luo V, Lakdawala H, Firestein BL
Automated Sholl analysis of digitized neuronal morphology at multiple scales.
J Vis Exp. 2010;(45) PubMed: 21113115PAPER Li X, Coyle D, Maguire L, Watson DR, McGinnity TM
Gray matter concentration and effective connectivity changes in Alzheimer's disease: a longitudinal structural MRI study.
Neuroradiology. 2011 Oct;53(10):733-48. PubMed: 21113707PAPER Camozzato AL, Kochhann R, Godinho C, Costa A, Chaves ML
Validation of a telephone screening test for Alzheimer's disease.
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2011 Mar;18(2):180-94. PubMed: 21113824PAPER Stravalaci M, Beeg M, Salmona M, Gobbi M
Use of surface plasmon resonance to study the elongation kinetics and the binding properties of the highly amyloidogenic Aβ(1-42) peptide, synthesized by depsi-peptide technique.
Biosens Bioelectron. 2011 Jan 15;26(5):2772-5. PubMed: 21112205PAPER Weiss R, Lifshitz V, Frenkel D
TGF-β1 affects endothelial cell interaction with macrophages and T cells leading to the development of cerebrovascular amyloidosis.
Brain Behav Immun. 2011 Jul;25(5):1017-24. PubMed: 21112386PAPER Cissé M, Halabisky B, Harris J, Devidze N, Dubal DB, Sun B, Orr A, Lotz G, Kim DH, Hamto P, Ho K, Yu GQ, Mucke L
Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.
Nature. 2011 Jan 6;469(7328):47-52. PubMed: 21113149PAPER Kapai NA, Solntseva EI, Skrebitskii VG
Donepezil eliminates suppressive effects of β-amyloid peptide (1-42) on long-term potentiation in the hippocampus.
Bull Exp Biol Med. 2010 Jul;149(1):33-6. PubMed: 21113452Current Filters
No filters selected